Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions
Journal of Diabetes Investigation · 2026-08 · 17 (8) · 1440-1441
DOI: 10.1111/jdi.70351 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 05.06.2026. Verfasst von Gargi Bisht und 1 weiteren Autor:innen. Beteiligte Einrichtung: Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar (Deemed To Be University), Ambala, Haryana, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar (Deemed To Be University), Ambala, Haryana, India.
ORCID-Profile: Gargi Bisht, Nitin Kumar Indora
Zitieren
APA
Bisht, G., & Indora, N. K. (2026). Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions. Journal of Diabetes Investigation, 17(8), 1440-1441. https://doi.org/10.1111/jdi.70351
Vancouver
Bisht G, Indora NK. Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions. Journal of Diabetes Investigation. 2026;17(8):1440-1441. doi:10.1111/jdi.70351
BibTeX
@article{Bisht2026,
author = {Bisht, Gargi and Indora, Nitin Kumar},
title = {Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions},
journal = {Journal of Diabetes Investigation},
year = {2026},
volume = {17},
number = {8},
pages = {1440--1441},
doi = {10.1111/jdi.70351}
}
EUVIMED